{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T20:41:23Z","timestamp":1762375283018},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2008,5,1]],"date-time":"2008-05-01T00:00:00Z","timestamp":1209600000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Treat Options Neurol"],"published-print":{"date-parts":[[2008,5]]},"DOI":"10.1007\/s11940-008-0019-8","type":"journal-article","created":{"date-parts":[[2008,5,15]],"date-time":"2008-05-15T14:15:30Z","timestamp":1210860930000},"page":"178-185","source":"Crossref","is-referenced-by-count":27,"title":["Progressive multifocal leukoencephalopathy"],"prefix":"10.1007","volume":"10","author":[{"given":"Allen J.","family":"Aksamit","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,5,16]]},"reference":[{"key":"19_CR1","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1128\/CMR.5.1.49","volume":"5","author":"E.O. Major","year":"1992","unstructured":"Major EO, Amemiya K, Tornatore CS, et al.: Pathogenesis and molecular biology of progressive multifocal leukoencephalopathy, the JC virus-induced demyelinating disease of the human brain [review]. Clin Microbiol Rev 1992, 5:49\u201373.","journal-title":"Clin Microbiol Rev"},{"key":"19_CR2","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1055\/s-2008-1040837","volume":"19","author":"J.R. Berger","year":"1999","unstructured":"Berger JR, Major EO: Progressive multifocal leukoencephalopathy [review]. Semin Neurol 1999, 19:193\u2013200.","journal-title":"Semin Neurol"},{"key":"19_CR3","doi-asserted-by":"crossref","first-page":"59","DOI":"10.3109\/13550289809113482","volume":"4","author":"J.R. Berger","year":"1998","unstructured":"Berger JR, Pall L, Lanska D, Witeman M: Progressive multifocal leukoencephalopathy in patients with HIV infection. J Neurovirol 1998, 4:59\u201368.","journal-title":"J Neurovirol"},{"key":"19_CR4","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/S0025-6196(12)60701-0","volume":"68","author":"A.J. Aksamit","year":"1993","unstructured":"Aksamit AJ: Nonradioactive in situ hybridization in progressive multifocal leukoencephalopathy. Mayo Clin Proc 1993, 68:899\u2013910.","journal-title":"Mayo Clin Proc"},{"key":"19_CR5","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1056\/NEJM198802043180507","volume":"318","author":"S.A. Houff","year":"1988","unstructured":"Houff SA, Major EO, Katz DA: Involvement of JC virus-infected mononuclear cells from the bone marrow and spleen in pathogenesis of progressive multifocal leukoencephalopathy. N Engl J Med 1988, 318:301\u2013305.","journal-title":"N Engl J Med"},{"key":"19_CR6","doi-asserted-by":"crossref","first-page":"68","DOI":"10.5414\/NPP26068","volume":"26","author":"S.G. Freim Wahl","year":"2007","unstructured":"Freim Wahl SG, Folvik MR, Torp SH: Progressive multifocal leukoencephalopathy in a lymphoma patient with complete remission after treatment with cytostatics and rituximab: case report and review of the literature. Clin Neuropathol 2007, 26:68\u201373.","journal-title":"Clin Neuropathol"},{"key":"19_CR7","unstructured":"Rituxan warning. FDA Consumer 2007, 41:3. http:\/\/www.fda.gov\/fdac\/departs\/2007\/207_upd.html ."},{"key":"19_CR8","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1212\/01.wnl.0000267325.06000.d9","volume":"69","author":"S.M. Kranick","year":"2007","unstructured":"Kranick SM, Mowry EM, Rosenfeld MR: Progressive multifocal leukoencephalopathy after rituximab in a case of non-Hodgkin lymphoma. Neurology 2007, 69:704\u2013706.","journal-title":"Neurology"},{"key":"19_CR9","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0733-8619(18)31105-8","volume":"2","author":"B.R. Brooks","year":"1984","unstructured":"Brooks BR, Walker DL: Progressive multifocal leukoencephalopathy. Neurol Clin 1984, 2:299\u2013313.","journal-title":"Neurol Clin"},{"key":"19_CR10","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1002\/ana.1004","volume":"49","author":"F. Weber","year":"2001","unstructured":"Weber F, Goldmann C, Kramer M: Cellular and humeral immune response in progressive multifocal leukoencephalopathy. Ann Neurol 2001, 49:636\u2013642.","journal-title":"Ann Neurol"},{"key":"19_CR11","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1093\/rheumatology\/kem049","volume":"46","author":"K. Owczarczyk","year":"2007","unstructured":"Owczarczyk K, Hilker R, Brunn A, et al.: Progressive multifocal leucoencephalopathy in a patient with sarcoidosis\u2014successful treatment with cidofovir and mirtazapine [letter]. Rheumatology (Oxford) 2007, 46:888\u2013890.","journal-title":"Rheumatology (Oxford)"},{"key":"19_CR12","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1056\/NEJMoa051782","volume":"353","author":"B.K. Kleinschmidt-DeMasters","year":"2005","unstructured":"Kleinschmidt-DeMasters BK, Tyler KL: Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1A for multiple sclerosis. N Engl J Med 2005, 353:369\u2013374.","journal-title":"N Engl J Med"},{"key":"19_CR13","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1056\/NEJMoa051847","volume":"353","author":"A. Langer-Gould","year":"2005","unstructured":"Langer-Gould A, Atlas S, Green AJ, et al.: Progressive multifocal leukoencephalopathy in a patient treated with natalizumab. N Engl J Med 2005, 353:375\u2013381.","journal-title":"N Engl J Med"},{"key":"19_CR14","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1001\/archneur.64.2.169","volume":"64","author":"O. Stuve","year":"2007","unstructured":"Stuve O, Marra CM, Cravens PD, et al.: Potential risk of progressive multifocal leukoencephalopathy with natalizumab therapy: possible interventions. Arch Neurol 2007, 64:169\u2013176.","journal-title":"Arch Neurol"},{"key":"19_CR15","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S1474-4422(07)70078-9","volume":"6","author":"L. Kappos","year":"2007","unstructured":"Kappos L, Bates D, Hartung HP, et al.: Natalizumab treatment for multiple sclerosis: recommendations for patient selection and monitoring. Lancet Neurol 2007, 6:431\u2013441.","journal-title":"Lancet Neurol"},{"key":"19_CR16","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1093\/brain\/81.1.93","volume":"81","author":"K.E. Astrom","year":"1958","unstructured":"Astrom KE, Mancall EL, Richardson EP: Progressive multifocal leukoencephalopathy. Brain 1958, 81:93\u2013110.","journal-title":"Brain"},{"key":"19_CR17","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/ana.20933","volume":"60","author":"I.J. Koralnik","year":"2006","unstructured":"Koralnik IJ: Progressive multifocal leukoencephalopathy revisited: Has the disease outgrown its name? Ann Neurol 2006, 60:162\u2013173.","journal-title":"Ann Neurol"},{"key":"19_CR18","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1148\/radiology.187.1.8451420","volume":"187","author":"M.L. Whiteman","year":"1993","unstructured":"Whiteman ML, Post MJ, Berger JR, et al.: Progressive multifocal leukoencephalopathy in 47 HIV-seropositive patients: neuroimaging with clinical and pathologic correlation. Radiology 1993, 187:233\u2013240.","journal-title":"Radiology"},{"key":"19_CR19","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1086\/427698","volume":"40","author":"S. Bossolasco","year":"2005","unstructured":"Bossolasco S, Calori G, Moretti F, et al.: Prognostic significance of JC virus DNA levels in cerebrospinal fluid of patients with HIV-associated progressive multifocal leukoencephalopathy. Clin Infect Dis 2005, 40:738\u2013744.","journal-title":"Clin Infect Dis"},{"key":"19_CR20","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/jemt.1070320405","volume":"32","author":"A.J. Aksamit","year":"1995","unstructured":"Aksamit AJ: Progressive multifocal leukoencephalopathy: a review of pathology and pathogenesis. Microsc Res Tech 1995, 32:302\u2013311","journal-title":"Microsc Res Tech"},{"key":"19_CR21","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1212\/WNL.52.3.623","volume":"52","author":"D.B. Clifford","year":"1999","unstructured":"Clifford DB, Yiannoutsos C, Glicksman M, et al.: HAART improves prognosis in HIV-associated progressive multifocal leukoencephalopathy. Neurology 1999, 52:623\u2013625.","journal-title":"Neurology"},{"key":"19_CR22","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1080\/13550280390195315","volume":"9","author":"R.A. Pasquier De","year":"2003","unstructured":"De Pasquier RA, Koralnik IJ: Inflammatory reaction in progressive multifocal leukoencephalopathy: harmful or beneficial? J Neurovirol 2003, 9:25\u201331.","journal-title":"J Neurovirol"},{"key":"19_CR23","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1212\/WNL.38.7.1060","volume":"38","author":"J.R. Berger","year":"1988","unstructured":"Berger JR, Mucke L: Prolonged survival and partial recovery in AIDS-associated progressive multifocal leukoencephalopathy. Neurology 1988, 38:1060\u20131065.","journal-title":"Neurology"},{"key":"19_CR24","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/ana.410130503","volume":"13","author":"R.W. Price","year":"1983","unstructured":"Price RW, Nielsen S, Horten B, et al.: Progressive multifocal leukoencephalopathy: a burnt-out case. Ann Neurol 1983, 13:485\u2013490.","journal-title":"Ann Neurol"},{"key":"19_CR25","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1212\/WNL.25.11.1007","volume":"25","author":"J.J. Kepes","year":"1975","unstructured":"Kepes JJ, Chou SM, Price LW Jr: Progressive multifocal leukoencephalopathy with 10-year survival in a patient with nontropical sprue. Report of a case with unusual light and electron microscopic features. Neurology 1975, 25:1006\u20131012.","journal-title":"Neurology"},{"key":"19_CR26","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/ana.410330415","volume":"33","author":"M.J. Steiger","year":"1993","unstructured":"Steiger MJ, Tarnesby G, Gabe S, et al.: Successful outcome of progressive multifocal leukoencephalopathy with cytarabine and interferon. Ann Neurol 1993, 33:407\u2013411.","journal-title":"Ann Neurol"},{"key":"19_CR27","doi-asserted-by":"crossref","first-page":"324","DOI":"10.3109\/13550289809114533","volume":"4","author":"S.S. Huang","year":"1998","unstructured":"Huang SS, Skolasky RL, Dal Pan GJ, et al.: Survival prolongation in HIV-associated progressive multifocal leukoencephalopathy treated with alpha-interferon: an observational study. J Neurovirol 1998, 4:324\u2013332.","journal-title":"J Neurovirol"},{"key":"19_CR28","first-page":"24","volume":"92","author":"C. Colosimo","year":"1992","unstructured":"Colosimo C, Lebon P, Martelli M, et al.: Alpha-interferon therapy in a case of probable progressive multifocal leukoencephalopathy. Acta Neurol Belg 1992, 92:24\u201329.","journal-title":"Acta Neurol Belg"},{"key":"19_CR29","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1080\/13550280152537238","volume":"7","author":"M. Geschwind","year":"2001","unstructured":"Geschwind M, Skolasky RL, Royal WS, McArthur JC: The relative contribution of HAART and alpha-interferon for therapy of progressive multifocal leukoencephalopathy in AIDS. J Neurovirol 2001, 7:353\u2013357.","journal-title":"J Neurovirol"},{"key":"19_CR30","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1212\/01.wnl.0000191322.93310.a1","volume":"66","author":"A. Nath","year":"2006","unstructured":"Nath A, Venkataramana A, Reich DS, et al.: Progression of progressive multifocal leukoencephalopathy despite treatment with \u03b2-interferon. Neurology 2006, 66:149\u2013150.","journal-title":"Neurology"},{"key":"19_CR31","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1016\/S0140-6736(05)63201-1","volume":"349","author":"J. Vollmer-Haase","year":"1997","unstructured":"Vollmer-Haase J, Young P, Ringelstein EB: Efficacy of camptothecin in progressive multifocal leukoencephalopathy [letter]. Lancet 1997, 349:1366.","journal-title":"Lancet"},{"key":"19_CR32","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1080\/13550280390201740","volume":"9","author":"W. Royal 3rd","year":"2003","unstructured":"Royal W 3rd, Dupont B, McGuire D, et al.: Topotecan in the treatment of acquired immunodeficiency syndrome-related progressive multifocal leukoencephalopathy. J Neurovirol 2003, 9:411\u2013419.","journal-title":"J Neurovirol"},{"key":"19_CR33","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1001\/jama.1973.03230020036009","volume":"226","author":"W.R. Bauer","year":"1973","unstructured":"Bauer WR, Turel AP Jr, Johnson KP: Progressive multifocal leukoencephalopathy and cytarabine. Remission with treatment. JAMA 1973, 226:174\u2013176.","journal-title":"JAMA"},{"key":"19_CR34","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/0140-6736(91)92504-U","volume":"337","author":"P. Portegies","year":"1991","unstructured":"Portegies P, Algra PR, Hollak CE, et al.: Response to cytarabine in progressive multifocal leucoencephalopathy in AIDS. Lancet 1991, 337:680\u2013681.","journal-title":"Lancet"},{"key":"19_CR35","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1056\/NEJM199805073381903","volume":"338","author":"C.D. Hall","year":"1998","unstructured":"Hall CD, Dafni U, Simpson D, et al.: Failure of cytarabine in progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. AIDS Clinical Trials Group 243 Team. N Engl J Med 1998, 338:1345\u20131351.","journal-title":"N Engl J Med"},{"key":"19_CR36","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1080\/13550280152537292","volume":"7","author":"A.J. Aksamit","year":"2001","unstructured":"Aksamit AJ: Treatment of non-AIDS progressive multifocal leukoencephalopathy with cytosine arabinoside. J Neurovirol 2001, 7:386\u2013390.","journal-title":"J Neurovirol"},{"key":"19_CR37","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s15010-006-5103-y","volume":"35","author":"J.F. Viallard","year":"2007","unstructured":"Viallard JF, Lazaro E, Ellie E, et al.: Improvement of progressive multifocal leukoencephalopathy after cidofovir therapy in a patient with a destructive polyarthritis. Infection 2007, 35:33\u201336.","journal-title":"Infection"},{"key":"19_CR38","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1086\/317539","volume":"32","author":"S. Houston","year":"2001","unstructured":"Houston S, Roberts N, Mashinter L: Failure of cidofovir therapy in progressive multifocal leukoencephalopathy unrelated to human immunodeficiency virus. Clin Infect Dis 2001, 32:150\u2013152.","journal-title":"Clin Infect Dis"},{"key":"19_CR39","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1080\/13550280152537274","volume":"7","author":"J. Gasnault","year":"2001","unstructured":"Gasnault J, Kousignian P, Kahraman M, et al.: Cidofovir in AIDS-associated progressive multifocal leukoencephalopathy: a monocenter observational study with clinical and JC virus load monitoring. J Neurovirol 2001, 7:375\u2013381.","journal-title":"J Neurovirol"},{"key":"19_CR40","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1080\/13550280152537256","volume":"7","author":"A. Luca De","year":"2001","unstructured":"De Luca A, Giancola ML, Ammassari A, et al.: Potent anti-retroviral therapy with or without cidofovir for AIDS-associated progressive multifocal leukoencephalopathy: extended follow-up of an observational study. J Neurovirol 2001, 7:364\u2013368.","journal-title":"J Neurovirol"},{"key":"19_CR41","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1097\/00002030-200209060-00012","volume":"16","author":"C.M. Marra","year":"2002","unstructured":"Marra CM, Rajicic N, Barker DE, et al.: Adult AIDS Clinical Trials Group 363 Team: A pilot study of cidofovir for progressive multifocal leukoencephalopathy in AIDS. AIDS 2002, 16:1791\u20131797.","journal-title":"AIDS"},{"key":"19_CR42","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1097\/01.qai.0000136093.47316.f3","volume":"37","author":"C. Wyen","year":"2004","unstructured":"Wyen C, Hoffmann, Schmeisser N, et al.: Progressive multifocal leukoencephalopathy in patients on highly active antiretroviral therapy. J Acquir Immune Defic Syndr 2004, 37:1263\u20131268.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"19_CR43","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.4065\/76.11.1171","volume":"76","author":"R.R. Razonable","year":"2001","unstructured":"Razonable RR, Aksamit AJ, Wright AJ, Wilson JW: Cidofovir treatment of progressive multifocal leukoencephalopathy in a patient receiving highly active antiretroviral therapy. Mayo Clin Proc 2001, 76:1171\u20131175.","journal-title":"Mayo Clin Proc"},{"key":"19_CR44","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1212\/WNL.52.4.891","volume":"52","author":"A. Luca De","year":"1999","unstructured":"De Luca A, Fantoni M, Tartaglione T, Antinori A: Response to cidofovir after failure of antiretroviral therapy alone in AIDS-associated progressive multifocal leukoencephalopathy [case report]. Neurology 1999, 52:891\u2013892.","journal-title":"Neurology"},{"key":"19_CR45","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1212\/01.wnl.0000242728.26433.12","volume":"67","author":"J.V. Martinez","year":"2006","unstructured":"Martinez JV, Mazziotti JV, Efron ED, et al.: Immune reconstitution inflammatory syndrome associated with PML in AIDS: a treatable disorder. Neurology 2006, 67:1692\u20131694.","journal-title":"Neurology"},{"key":"19_CR46","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1212\/01.WNL.0000148585.41802.6C","volume":"63","author":"S. Giambenedetto Di","year":"2004","unstructured":"Di Giambenedetto S, Vago G, Pompucci A, et al.: Fatal inflammatory AIDS-associated PML with high CD4 counts on HAART: a new clinical entity? Neurology 2004, 63:2452\u20132453.","journal-title":"Neurology"},{"key":"19_CR47","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1126\/science.1103492","volume":"306","author":"G.F. Elphick","year":"2004","unstructured":"Elphick GF, Querbes W, Jordan JA, et al.: The human polyomavirus JCV uses serotonin receptors to infect cells. Science 2004, 306:1380\u20131383.","journal-title":"Science"},{"key":"19_CR48","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1136\/jnnp.2006.092353","volume":"77","author":"S. Vulliemoz","year":"2006","unstructured":"Vulliemoz S, Lurati-Ruiz F, Borruat FX, et al.: Favourable outcome of progressive multifocal leucoencephalopathy in two patients with dermatomyositis. J Neurol Neurosurg Psychiatry 2006, 77:1079\u20131082.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"19_CR49","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/sj.bmt.1705682","volume":"39","author":"R.E. Kast","year":"2007","unstructured":"Kast RE, Focosi D, Petrini M, Altschuler EL: Treatment schedules for 5-HT2A blocking in progressive multifocal leukoencephalopathy using risperidone or ziprasidone [letter]. Bone Marrow Transplant 2007, 39:811\u2013812.","journal-title":"Bone Marrow Transplant"}],"container-title":["Current Treatment Options in Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11940-008-0019-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11940-008-0019-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11940-008-0019-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T00:56:52Z","timestamp":1559437012000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11940-008-0019-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,5]]},"references-count":49,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,5]]}},"alternative-id":["19"],"URL":"https:\/\/doi.org\/10.1007\/s11940-008-0019-8","relation":{},"ISSN":["1092-8480","1534-3138"],"issn-type":[{"value":"1092-8480","type":"print"},{"value":"1534-3138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,5]]}}}